Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Change in Acquisitions & Divestments: 2020-2025

Historic Change in Acquisitions & Divestments for InMed Pharmaceuticals (INM) over the last 4 years, with Jun 2025 value amounting to $42,270.

  • InMed Pharmaceuticals' Change in Acquisitions & Divestments fell 1.72% to $20,957 in Q3 2025 from the same period last year, while for Sep 2025 it was $41,903, marking a year-over-year decrease of 33.91%. This contributed to the annual value of $42,270 for FY2025, which is 0.45% up from last year.
  • Latest data reveals that InMed Pharmaceuticals reported Change in Acquisitions & Divestments of $42,270 as of FY2025, which was up 0.45% from $42,082 recorded in FY2024.
  • InMed Pharmaceuticals' Change in Acquisitions & Divestments' 5-year high stood at $42,270 during FY2025, with a 5-year trough of $42,082 in FY2024.
  • Its 3-year average for Change in Acquisitions & Divestments is $42,207, with a median of $42,268 in 2023.
  • Per our database at Business Quant, InMed Pharmaceuticals' Change in Acquisitions & Divestments decreased by 0.44% in 2024 and then rose by 0.45% in 2025.
  • Yearly analysis of 3 years shows InMed Pharmaceuticals' Change in Acquisitions & Divestments stood at $42,268 in 2023, then declined by 0.44% to $42,082 in 2024, then increased by 0.45% to $42,270 in 2025.